BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
67.48
-0.84 (-1.23%)
At close: Apr 3, 2025, 4:00 PM
66.31
-1.17 (-1.74%)
After-hours: Apr 3, 2025, 7:21 PM EDT

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
942.84755.13724.53587.28649.16
Upgrade
Short-Term Investments
194.86318.68567.01426.6416.23
Upgrade
Cash & Short-Term Investments
1,1381,0741,2921,0141,065
Upgrade
Cash Growth
5.95%-16.86%27.39%-4.83%41.33%
Upgrade
Accounts Receivable
660.54633.7461.32373.4448.35
Upgrade
Receivables
660.54633.7461.32373.4448.35
Upgrade
Inventory
1,2331,107894.08776.67698.55
Upgrade
Other Current Assets
201.53141.39104.52110.44129.93
Upgrade
Total Current Assets
3,2322,9562,7512,2742,342
Upgrade
Property, Plant & Equipment
1,0771,1121,1141,0821,090
Upgrade
Long-Term Investments
527.84622.44370.34524.29295.97
Upgrade
Goodwill
196.2196.2196.2196.2196.2
Upgrade
Other Intangible Assets
327.38325.3338.57388.65417.27
Upgrade
Long-Term Deferred Tax Assets
1,4891,5461,5051,4501,432
Upgrade
Other Long-Term Assets
138.9483.5698.7889.274.63
Upgrade
Total Assets
6,9896,8426,3756,0055,848
Upgrade
Accounts Payable
235.4315.51231.24199.68191.43
Upgrade
Accrued Expenses
331.27311.55293.53267.65257.27
Upgrade
Current Portion of Long-Term Debt
-493.88---
Upgrade
Current Portion of Leases
7.578.7810.3810.4611.75
Upgrade
Current Income Taxes Payable
12.572.6516.211.219.66
Upgrade
Current Unearned Revenue
1.374.620.716.960.15
Upgrade
Other Current Liabilities
18.840.0436.8160.5422.29
Upgrade
Total Current Liabilities
606.991,177588.88546.5492.55
Upgrade
Long-Term Debt
595.14593.11,0831,0791,075
Upgrade
Long-Term Leases
31.2638.1226.5133.8444.49
Upgrade
Other Long-Term Liabilities
97.5781.8173.579.69129.84
Upgrade
Total Liabilities
1,3311,8901,7721,7391,742
Upgrade
Common Stock
0.190.190.190.180.18
Upgrade
Additional Paid-In Capital
5,8025,6125,4055,1924,993
Upgrade
Retained Earnings
-194.7-621.55-789.2-930.76-861.61
Upgrade
Comprehensive Income & Other
50.43-38.65-12.734.74-25.98
Upgrade
Shareholders' Equity
5,6584,9524,6034,2664,106
Upgrade
Total Liabilities & Equity
6,9896,8426,3756,0055,848
Upgrade
Total Debt
633.971,1341,1201,1231,131
Upgrade
Net Cash (Debt)
503.74-60.07171.63-109.51-66
Upgrade
Net Cash Per Share
2.56-0.310.91-0.60-0.34
Upgrade
Filing Date Shares Outstanding
190.78188.68186.53184.03181.83
Upgrade
Total Common Shares Outstanding
190.76188.6186.25183.91181.74
Upgrade
Working Capital
2,6251,7792,1631,7281,850
Upgrade
Book Value Per Share
29.6626.2524.7123.1922.59
Upgrade
Tangible Book Value
5,1344,4304,0683,6813,493
Upgrade
Tangible Book Value Per Share
26.9223.4921.8420.0119.22
Upgrade
Land
90.7890.7890.7990.4290.42
Upgrade
Buildings
892.48860.81819.1774.92761.56
Upgrade
Machinery
789.5796.61736.25688.54644.4
Upgrade
Construction In Progress
90.27100.01143.38136.74109.14
Upgrade
Leasehold Improvements
44.3758.2359.5355.2855.13
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q